“Antivitamins” could be the cure for antibiotic resistance

There’s a promising new lead in the fight against superbugs.

Nearly a century ago, the discovery of penicillin — the first naturally-occurring bacteria-killer — spurred the creation of an entirely new class of medicines: antibiotics.

Armed with these drugs, doctors finally had a way to combat the bacterial infections that were the top cause of death at the time. But decades of overuse has had a deadly side effect: some bacteria have evolved to resist once-effective antibiotics, a problem dubbed “antibiotic resistance.”

“Antibiotic resistance is a global crisis that we cannot ignore,” Tedros Adhanom Ghebreyesus, Director-General of the WHO, said in 2017.

“If we don’t tackle this threat with strong, coordinated action,” he continued, “antimicrobial resistance will take us back to a time when people feared common infections and risked their lives from minor surgery.”

Now, a University of Göttingen-led research team has a new lead in the hunt for effective weapons against these superbugs: antivitamins.

Stopping Superbugs

As the name suggests, antivitamins are substances that interfere with the function of vitamins.

Researchers at Göttingen knew that some bacteria produce an antivitamin for vitamin B1, which kills off other bacteria in their environment, essentially wiping out their competition.

However, they didn’t know exactly how the antivitamin did this — and that’s the question they sought to answer with their new study, published in the journal Nature Chemical Biology.

Because the B1 antivitamin is nearly identical to the vitamin itself — it has just one extra atom — the researchers decided to focus on that atom.

Antibiotic resistance is a global crisis that we cannot ignore.


Tedros Adhanom Ghebreyesus

When they exposed drug-resistant E. coli to the B1 antivitamin, they found that the extra atom interfered with the function of one protein in the bacteria’s metabolic processes.

“Just one extra atom in the antivitamin acts like a grain of sand in a complex gear system by blocking its finely tuned mechanics,” researcher Kai Tittmann said in a press release.

They then used computer simulations to model how the antivitamin would affect humans and determined that our proteins either wouldn’t bind to it or wouldn’t be “poisoned” by it.

Based on this new research, the Göttingen team believes the B1 antivitamin holds promise as the basis for a new antibiotic, though further research in animals and humans would be needed to confirm the theory.

Antibiotic Resistance in the Crosshairs

Even if the B1 antivitamin proves to be a dead end in the hunt for solutions to antibiotic resistance, though, the scientific community has plenty of other leads.

MIT researchers recently developed an AI capable of quickly analyzing thousands of compounds for antimicrobial properties. That research led to the discovery of a molecule called halicin that shows promise as a powerful new antibiotic.

Then there are the researchers looking for ways to train our own bodies to fight antibiotic-resistant superbugs, eliminating some of the need for antibiotics altogether.

Still others are looking to medieval medicine for answers to the modern problem of antibiotic resistance — and if that isn’t hardcore enough, some scientists are discovering potential weapons against superbugs in the blood of dragons.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

Related
Axolotls can regenerate their brains
Axolotls are a model organism researchers use to study a variety of topics in biology because of their regenerative abilities.
New treatment “starves” aggressive brain tumors in mice
A treatment that “starved” aggressive glioblastoma tumors in the brains of mice suggests a way to finally fight the deadly cancer in humans.
Meth addiction treatments are finally on the horizon
New antibody and drug therapies may soon help treat meth patients, who currently have no pharmacological interventions.
Blood test can find dozens of types of cancer, with few false positives
Grail’s Galleri multi-cancer blood test found multiple cancers in a study of over 6,000 patients.
ARPA-H: High-risk, high-reward health research is the mandate of new, billion-dollar US agency 
A new multibillion-dollar federal agency was created with a goal of supporting “the next generation of moonshots for health.”
Up Next
COVID-19 Saliva Test
Subscribe to Freethink for more great stories